Automated description from the Alliance of Genome Resources (Release 7.4.0)
Predicted to enable 11-beta-hydroxysteroid dehydrogenase (NAD+) activity; NAD binding activity; and steroid binding activity. Acts upstream of or within female pregnancy. Predicted to be located in endoplasmic reticulum. Predicted to be active in intracellular membrane-bounded organelle. Is expressed in several structures, including brain; ear; genitourinary system; hemolymphoid system; and trophectoderm. Human ortholog(s) of this gene implicated in apparent mineralocorticoid excess syndrome; hypertension; inherited metabolic disorder; obesity; and type 1 diabetes mellitus. Orthologous to human HSD11B2 (hydroxysteroid 11-beta dehydrogenase 2).
This site uses cookies.
Some cookies are essential for site operations and others help us analyze use and utility of our web site.
Please refer to our
privacy policy
for more information.